These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 8658960

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of dose of cyclosporine or FK506 and antithrombotic agents on cardiac allograft vascular disease in heterotopically transplanted hearts in rats.
    Hisatomi K, Isomura T, Ohashi M, Tamehiro K, Sato T, Tayama E, Ohishi K, Kohjiro M.
    J Heart Lung Transplant; 1995; 14(1 Pt 1):113-8. PubMed ID: 7537098
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H, Takahashi M, Kaneko T, Murakami T, Hakamata Y, Kudou S, Kishi T, Fukuchi K, Iwanami S, Kuriyama K, Yasue T, Enosawa S, Matsumoto K, Takeyoshi I, Morishita Y, Kobayashi E.
    Circulation; 2005 Jan 18; 111(2):222-9. PubMed ID: 15642767
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the use of brequinar sodium and cyclosporine combination therapy for preventing rat cardiac allograft rejection.
    Cosenza CA, Cramer DV, Eiras-Hreha G, Cajulis E, Wang HK, Makowka L.
    Transplant Proc; 1993 Jun 18; 25(3 Suppl 2):57-8. PubMed ID: 8516945
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of combined administration of low dose cyclosporine A with a thromboxane synthetase inhibitor on acute cardiac allograft rejection.
    Sakurai Y, Kagawa K, Kato Y, Otani H, Nonoyama A.
    Transplant Proc; 1990 Aug 18; 22(4):1686-8. PubMed ID: 2389433
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Degree of HLA mismatch as a predictor of death from allograft arteriopathy after heart transplant.
    Cocanougher B, Ballantyne CM, Pollack MS, Payton-Ross C, Lowry R, Kleiman NS, Farmer JA, Noon GP, Short HD, Young JB.
    Transplant Proc; 1993 Feb 18; 25(1 Pt 1):233-6. PubMed ID: 8438282
    [No Abstract] [Full Text] [Related]

  • 18. FK 506 fails to reverse moderate cardiac allograft rejection in a canine heterotopic model.
    DeValeria PA, Gillinov AM, Chacko VP, Handa N, Bando K, Hutchins GM, Reitz BA, Baumgartner WA.
    Transplant Proc; 1991 Dec 18; 23(6):3288-90. PubMed ID: 1721438
    [No Abstract] [Full Text] [Related]

  • 19. Induction therapy with an immunomodulatory CD2 antibody does not inhibit allograft vasculopathy after rat heart transplantation.
    Dengler TJ, Szabo G, Amann K, Nottmeyer W, Vahl C, Hagl S, Zimmermann R.
    Transplant Proc; 1998 May 18; 30(3):868-70. PubMed ID: 9595130
    [No Abstract] [Full Text] [Related]

  • 20. Early experience with cyclosporine: a historic perspective.
    Kostakis A.
    Transplant Proc; 2004 Mar 18; 36(2 Suppl):22S-24S. PubMed ID: 15041302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.